Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bryan Daehahn Choi, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Bryan Choi and Marcela Maus.
Connection Strength

4.919
  1. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. J Immunother Cancer. 2019 11 14; 7(1):304.
    View in: PubMed
    Score: 0.844
  2. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nat Biotechnol. 2019 09; 37(9):1049-1058.
    View in: PubMed
    Score: 0.826
  3. Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeons. Neurosurg Focus. 2018 06; 44(6):E13.
    View in: PubMed
    Score: 0.763
  4. Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma. J Target Ther Cancer. 2017 Aug; 6(4):22-25.
    View in: PubMed
    Score: 0.720
  5. Commentary: Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment. Neurosurgery. 2021 06 15; 89(1):E68-E69.
    View in: PubMed
    Score: 0.236
  6. Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources. J Immunother Cancer. 2020 09; 8(2).
    View in: PubMed
    Score: 0.223
  7. A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq. Mol Ther. 2020 12 02; 28(12):2577-2592.
    View in: PubMed
    Score: 0.221
  8. Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Adv. 2019 11 12; 3(21):3248-3260.
    View in: PubMed
    Score: 0.211
  9. Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19. Clin Cancer Res. 2019 12 01; 25(23):7046-7057.
    View in: PubMed
    Score: 0.208
  10. Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma. Blood. 2019 09 12; 134(11):860-866.
    View in: PubMed
    Score: 0.206
  11. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function. JCI Insight. 2019 03 14; 5.
    View in: PubMed
    Score: 0.201
  12. Immunotherapy for Glioblastoma: Adoptive T-cell Strategies. Clin Cancer Res. 2019 04 01; 25(7):2042-2048.
    View in: PubMed
    Score: 0.197
  13. Safety and Efficacy of Tisagenlecleucel in Primary CNS Lymphoma: A phase I/II clinical trial. Blood. 2022 Feb 15.
    View in: PubMed
    Score: 0.062
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.